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Introduction: Frequent use of highly concentrated solutions may induce toxic side 
effects and cellular damage at the ocular surface. To enhance the amount of active 
substance reaching the target tissue or exerting a local effect in the cul-de-sac, the 
residence time of the drug in the tear film should be lengthened. The purpose of the 
study was to formulate biodegradable film loading nanoparticles (NPs) as 
ophthalmic insert, which could be easily placed into the cul-de-sac, and be capable 
of delivering therapeutic concentrations of Erythromycin for a prolonged period of 
time in a much lower dose. 
 
Methods and Results: A Novel quasi-emulsion solvent diffusion method to prepare 
the controlled-release nanoparticles of drug model with Eudragit polymers has been 
developed. FTIR and scanning electron microscopy (SEM), loading analyses of the 
nanoparticles, mechanical properties, water vapor permeability, thermal stability of 
the films were analyzed. An agar well diffusion bioassay method for determination 
of erythromycin in ophthalmic samples, using Micrococcus Luteus ATCC 9341 as 
the assay organism, was carried out. In vivo studies were performed in New Zealand 
albino rabbits using a film loading nanoparticles. SEM revealed irregularly shaped 
particles. Mean particle size of nanoparticles ranged between 118 and 203 nm, while 
zeta potential ranged between +15 and +22 mV. The inserts were found to be 
uniform, tough, elastic and bioadhesive. In-vitro release studies were performed and 
slowed release up to 28 h with non-Fickian diffusion behavior. Drug levels in the 
ocular tears in rabbit were significantly higher in comparison to treatment with a 
pomade formulation.  
 
Conclusions: Erythromycin NPs loaded Eudragit were successfully prepared by 
spontaneous emulsification technique. The insert would degrade during the specified 
time with no residue to be removed after the medication. 
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